MM
RXRX icon

MQS Management’s Recursion Pharmaceuticals RXRX Stock Holding History

MQS Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.1K Buy
+13,399
New +$51.8K 0.03% 365

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MQS Management's RXRX Position: Q1 2026 in Review

MQS Management opened a new position in Recursion Pharmaceuticals (RXRX) in Q1 2026: 13,399 shares worth $41.1K. The stake represents 0.03% of the portfolio and ranks #365 among its holdings.

334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • MQS Management held 13,399 shares of Recursion Pharmaceuticals worth $41.1K as of Q1 2026.
  • Recursion Pharmaceuticals was a new MQS Management position in Q1 2026.
  • Recursion Pharmaceuticals made up 0.03% of MQS Management's portfolio in Q1 2026, its #365 holding.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on MQS Management's 13F filing for Q1 2026, filed 23 Apr 2026.